"Principle Test for Isolation and Characterization of Circulating Cancer Cells (CTC)-CXCR4+."

NAActive, not recruitingINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

January 18, 2021

Primary Completion Date

March 22, 2022

Study Completion Date

December 31, 2025

Conditions
Neoplasm Malignant
Interventions
DEVICE

CLG

"The development of an innovative device (CLG) consisting of an aqueous gel based on hyaluronic acid and commercially available (Belotero) able to be loaded and to release chemokine CXCL12 recreating a kind of fake niche able to attract immune cells- and CTCs-CXCR4+. The added value is the ability to attract and trap cells capable of leaking out and potentially with a higher metastatic capacity."

Trial Locations (2)

Unknown

Istitute Nazionale Tumori - Fondazione G. Pascale, Napoli

"Istituto Nazionale Tumori - Fondazione G.Pascale, IRCCS", Napoli

All Listed Sponsors
lead

National Cancer Institute, Naples

OTHER